Following the news of the discovery of a solution to Covid-19 virus by the Gamaleya Research Center in Russia, the website of the State Register of Pharmaceuticals has said the COVID-19 vaccine will be in circulation January 2021.
The website stated on Tuesday that the vaccine will not be available for public use until 1 January 2021, “Date of introduction to the civilian circulation – 01.01.2021,” the site announced.
The Russia’s health ministry registered the vaccine on Tuesday and the first user was one of President Vladimir Vladimirovich Putin’s daughter.
The Vaccine was developed by the Gamaleya Research Center and has Binnopharm JSC and the Gamaleya research centre listed as manufacturers.
It is said that the vaccine will exist in two forms, as a liquid and a freeze-dried one.
Russia’s Minister of Health, Mikhail Albertovich Murashko said, “technical regulations are being worked through in order to scale the production on sites of several domestic manufacturers,” TASS reported.